Liver transplantation for late-onset ornithine transcarbamylase deficiency : A case report
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved..
BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) is an X-linked inherited disorder and characterized by marked elevation of blood ammonia. The goal of treatment is to minimize the neurological damage caused by hyperammonemia. OTCD can be cured by liver transplantation (LT). Post-transplant patients can discontinue anti- hyperammonemia agents and consume a regular diet without the risk of developing hyperammonemia. The neurological damage caused by hyperammonemia is almost irreversible.
CASE SUMMARY: An 11.7-year-old boy presented with headache, vomiting, and altered consciousness. The patient was diagnosed with late-onset OTCD. After nitrogen scavenging treatment and a protein-free diet, ammonia levels were reduced to normal on the third day of admission. Nevertheless, the patient remained in a moderate coma. After discussion, LT was performed. Following LT, the patient's blood ammonia and biochemical indicators stabilized in the normal range, he regained consciousness, and his nervous system function significantly recovered. Two months after LT, blood amino acids and urine organic acids were normal, and brain magnetic resonance imaging showed a decrease in subcortical lesions.
CONCLUSION: LT can significantly improve partial neurological impairment caused by late-onset OTCD hyperammonemic encephalopathy, and LT can be actively considered when early drug therapy is ineffective.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
World journal of clinical cases - 10(2022), 18 vom: 26. Juni, Seite 6156-6162 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fu, Xiao-Hui [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Revised 13.08.2022 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.12998/wjcc.v10.i18.6156 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344691950 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344691950 | ||
003 | DE-627 | ||
005 | 20231226023349.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12998/wjcc.v10.i18.6156 |2 doi | |
028 | 5 | 2 | |a pubmed24n1148.xml |
035 | |a (DE-627)NLM344691950 | ||
035 | |a (NLM)35949846 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fu, Xiao-Hui |e verfasserin |4 aut | |
245 | 1 | 0 | |a Liver transplantation for late-onset ornithine transcarbamylase deficiency |b A case report |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 13.08.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
520 | |a BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) is an X-linked inherited disorder and characterized by marked elevation of blood ammonia. The goal of treatment is to minimize the neurological damage caused by hyperammonemia. OTCD can be cured by liver transplantation (LT). Post-transplant patients can discontinue anti- hyperammonemia agents and consume a regular diet without the risk of developing hyperammonemia. The neurological damage caused by hyperammonemia is almost irreversible | ||
520 | |a CASE SUMMARY: An 11.7-year-old boy presented with headache, vomiting, and altered consciousness. The patient was diagnosed with late-onset OTCD. After nitrogen scavenging treatment and a protein-free diet, ammonia levels were reduced to normal on the third day of admission. Nevertheless, the patient remained in a moderate coma. After discussion, LT was performed. Following LT, the patient's blood ammonia and biochemical indicators stabilized in the normal range, he regained consciousness, and his nervous system function significantly recovered. Two months after LT, blood amino acids and urine organic acids were normal, and brain magnetic resonance imaging showed a decrease in subcortical lesions | ||
520 | |a CONCLUSION: LT can significantly improve partial neurological impairment caused by late-onset OTCD hyperammonemic encephalopathy, and LT can be actively considered when early drug therapy is ineffective | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Case report | |
650 | 4 | |a Hyperammonemic encephalopathy | |
650 | 4 | |a Liver transplantation | |
650 | 4 | |a Ornithine transcarbamylase deficiency | |
650 | 4 | |a Urea cycle disorder | |
700 | 1 | |a Hu, Yu-Hui |e verfasserin |4 aut | |
700 | 1 | |a Liao, Jian-Xiang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Li |e verfasserin |4 aut | |
700 | 1 | |a Hu, Zhan-Qi |e verfasserin |4 aut | |
700 | 1 | |a Wen, Jia-Lun |e verfasserin |4 aut | |
700 | 1 | |a Chen, Shu-Li |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t World journal of clinical cases |d 2013 |g 10(2022), 18 vom: 26. Juni, Seite 6156-6162 |w (DE-627)NLM233331727 |x 2307-8960 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2022 |g number:18 |g day:26 |g month:06 |g pages:6156-6162 |
856 | 4 | 0 | |u http://dx.doi.org/10.12998/wjcc.v10.i18.6156 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2022 |e 18 |b 26 |c 06 |h 6156-6162 |